MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 15:06 Uhr</div>[url=https://www.facebook.com/public/Zoya-Demidenko/]Zoya Demidenko[/url]: Researcher in Tumor Studies [url=https://www.benthamdirect.com/content/journals/cpd/22/16]Zoya Demidenko[/url] is a distinguished investigator connected with the Unit of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she was employed at the NIH and New York Medical College, establishing a robust base in biomedical study. Her academic output spans a number of critical areas, among them the PI3K/AKT/mTOR molecular pathway, cellular cycle regulation, cellular aging, and tumor biology. As of now, she has co-authored over 46 peer-reviewed articles, which have accumulated upwards of 4,100 citations — a indicator to the significance of her research. One of her most significant discoveries lies in explaining the mechanisms of cell aging. Her research showed that when the cell cycle is blocked while cellular growth persists, the cells experience senescence. Importantly, [url=https://www.benthamdirect.com/content/journals/cpd/22/16]Zoya Demidenko[/url] established that this process can be controlled with drugs using agents such as rapamycin. [url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P]Zoya Demidenko[/url] has also contributed considerably to oncological therapy research, particularly in the field of selective cell protection — a method intended to safeguarding healthy tissue from cytotoxic treatment whilst leaving cancer cells susceptible. This strategy carries significant potential for lowering the toxic effects of oncological therapy. Throughout her scientific life, Demidenko has partnered with prominent scientists globally, such as Dr. Mikhail Blagosklonny. Her publications appears in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: Possessing an h-index of 33, [url=https://www.oncotarget.com/article/4836/]Zoya Demidenko[/url] stands as a influential voice in modern cancer science, with her discoveries go on to shape our comprehension of the way biological cells age, resist treatment, and how cancer might be more successfully treated. https://www.facebook.com/public/Zoya-Demidenko/</blockquote><br> Abbrechen
